Harleysville, PA, United States of America

Annette S Kim

This inventor holds 3 USPTO granted patents. Top assignee: Merck + Co., Inc.. Active years: 2008-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Annette S Kim. Retrieved from https://idiyas.com/inventor/annette-s-kim

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2008-2009

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Annette S Kim: Innovator in Tyrosine Kinase Inhibitors

Introduction

Annette S Kim is a notable inventor based in Harleysville, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of tyrosine kinase inhibitors. With a total of 3 patents to her name, her work has the potential to impact various therapeutic areas.

Latest Patents

Among her latest patents, Annette has focused on compounds that are capable of inhibiting, modulating, and regulating signal transduction of both receptor-type and non-receptor type tyrosine kinases. The compounds she has developed possess a core structure that includes a substituted pyrrole moiety. Additionally, her inventions relate to the pharmaceutically acceptable salts, hydrates, and stereoisomers of these compounds.

Career Highlights

Annette S Kim is currently associated with Merck & Co., Inc., where she continues to advance her research in the pharmaceutical industry. Her expertise in the field has led to innovative solutions that address critical health challenges.

Collaborations

One of her notable coworkers is Xufang Zhang, who collaborates with her on various projects within the company.

Conclusion

Annette S Kim's contributions to the field of tyrosine kinase inhibitors exemplify her dedication to innovation in pharmaceuticals. Her work not only enhances our understanding of these compounds but also paves the way for future advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…